Outcome and prognostic factors during the course of primary small-vessel vasculitides

Journal of Rheumatology

Volumn 33, Issue 7, 2006, Pages 1299-1306

  Pavone, Laura ^a   Grasselli, Chiara ^a   Chierici, Elisabetta ^a   Maggiore, Umberto ^a   Garini, Gianni ^a   Ronda, Nicoletta ^a   Manganelli, Paolo ^b   Pesci, Alberto ^a   Troise Rioda, Walter ^b   Tumiati, Bruno ^c   Pavesi, Giovanni ^a   Vaglio, Augusto ^a   Buzio, Carlo ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Churg Strauss syndrome; Microscopic polyangiitis; Onset season; PAUC1 immune small vessel vasculitis; Prognostic factors; Wegener's granulomatosis

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; METHOTREXATE; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADOLESCENT; AGED; ARTICLE; CHURG STRAUSS SYNDROME; CORRELATION ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RELAPSE; RISK; RISK ASSESSMENT; SMALL VESSEL VASCULITIS; STAPHYLOCOCCUS AUREUS; SURVIVAL; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHURG-STRAUSS SYNDROME; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; ITALY; MALE; MICROCIRCULATION; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 33745775665     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Watts RA, Lane SE, Bentham G, Scott DGI. Epidemiology of systemic vasculitis: A ten year study in the United Kingdom. Arthritis Rheum 2000;43:414-9.
2. Frohnert PP, Sheps SG. Long-term follow up study of periarteritis nodosa. Am J Med 1967;43:8-14.
3. Fauci AS, Katz P, Haynes BF, Wolff SM. Cyclophosphamide therapy of severe necrotizing vasculitis. N Engl J Med 1979;301:235-8.
4. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine Baltimore 1996;75:17-28.
5. Fortin PR, Larson MG, Watters AK, Yeadon CA, Choquette D, Esdaile JM. Prognostic factors in systemic necrotizing vasculitis of the polyarteritis nodosa group. A review of 45 cases. J Rheumatol 1995;22:78-84.
6. Mahr A, Girard T, Agher R, Guillevin L. Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up. Rheumatology Oxford 2001;40:492-8.
7. Koldingsnes W, Nossent H. Predictors of survival and organ damage in Wegener's granulomatosis. Rheumatology Oxford 2002;41:572-81.
8. Reinhold-Keller E, Beuge N, Latza U, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long term outcome in 155 patients. Arthritis Rheum 2000;43:1021-32.
9. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
10. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
11. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
12. Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999;42:421-30.
13. Jennette JC, Thomas DB, Falk RJ. Microscopic polyangiitis (microscopic polyarteritis). Semin Diagn Pathol 2001;18:3-13.
14. Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-8.
15. Luqmani RA, Exley AR, Kitas GD, Bacon PA. Disease assessment and management of the vasculitides. Baillieres Clin Rheumatol 1997;11:423-46.
16. Grambsch PM, Therneau TM. Proportional hazard tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-26.
17. Royston P. Multiple imputation of missing values. Stata Journal 2004;4:227-41.
18. Gordon M, Luqmani RA, Adu D, et al. Relapses in patients with a systemic vasculitis. QJM 1993;86:779-89.
19. Sanders JS, Slot MC, Stegeman CA. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:2072-3.
20. Hogan SL, Nachman PH, Jennette JC, et al. The role of ANCA pattern and diagnosis in clinical presentation and outcomes in ANCA-associated small vessel vasculitis (ANCASVV) [abstract]. J Am Soc Nephrol 1999;10:104A.
21. Booth AD, Almond MK, Burns A, et al. Outcome of ANCA-associated renal vasculitis: a 5 year retrospective study. Am J Kidney Dis 2003;41:776-84.
22. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim- sulfamethoxazole (co-trimoxazole) for the prevention of relapses in Wegener's granulomatosis. N Engl J Med 1996;335:16-20.
23. Pesanti EL. Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 2001;15:813-32.
24. Mojcik CF, Klippel JH. End-stage renal disease and systemic lupus erythematosus. Am J Med 1996;101:100-7.
25. Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 1998;9:1258-63.
26. Gayraud M, Guillevin L, le Toumelin P, et al. Long-term follow up of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Arthritis Rheum 2001;44:666-75.
27. Raynauld JP, Bloch DA, Fries JF. Seasonal variation in the onset of Wegener's granulomatosis, polyarteritis nodosa and giant cell arteritis. J Rheumatol 1993;20:1524-6.
28. Carruthers DM, Watts RA, Symmons DP, Scott DG. Wegener's granulomatosis - increased incidence or increased recognition? Br J Rheumatol 1996;35:142-5.
29. Watts RA, Lane SE, Scott DG, et al. Epidemiology of vasculitis in Europe. Ann Rheum Dis 2001;60:1156-7.